Naoko Chayahara

1.9k total citations · 1 hit paper
44 papers, 1.4k citations indexed

About

Naoko Chayahara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Naoko Chayahara has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Naoko Chayahara's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Naoko Chayahara is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Naoko Chayahara collaborates with scholars based in Japan, United States and Ireland. Naoko Chayahara's co-authors include Hironobu Minami, Naomi Kiyota, Yoshinori Imamura, Toru Mukohara, Masanori Toyoda, Yohei Funakoshi, Yohei Shimono, Seishi Kono, Shintaro Takao and Tetsuya Nakatsura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Naoko Chayahara

43 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

2015 639 citations Yoshinori Imamura, Toru Mukohara et al. Oncology Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoko Chayahara Japan	18	577	381	356	287	252	44	1.4k
Masanori Toyoda Japan	17	592 1.0×	395 1.0×	373 1.0×	61 0.2×	301 1.2×	71	1.6k
Thomas Krahn Germany	18	593 1.0×	236 0.6×	340 1.0×	71 0.2×	215 0.9×	45	1.6k
Haiyan Yang China	23	498 0.9×	182 0.5×	604 1.7×	61 0.2×	404 1.6×	84	1.6k
Ashique Rafique United States	18	355 0.6×	93 0.2×	792 2.2×	182 0.6×	181 0.7×	37	2.3k
Magdalena Winiarska Poland	20	390 0.7×	199 0.5×	432 1.2×	49 0.2×	240 1.0×	63	1.4k
Dapeng Li China	20	399 0.7×	140 0.4×	783 2.2×	295 1.0×	209 0.8×	84	1.8k
Maria P. Morgan Ireland	19	377 0.7×	176 0.5×	386 1.1×	61 0.2×	145 0.6×	33	1.2k
Sang‐Yeob Kim South Korea	24	440 0.8×	266 0.7×	797 2.2×	43 0.1×	240 1.0×	81	1.6k
Dongjun Jeong South Korea	21	528 0.9×	99 0.3×	798 2.2×	62 0.2×	268 1.1×	55	1.6k
Krzysztof Moroz United States	23	429 0.7×	81 0.2×	854 2.4×	160 0.6×	302 1.2×	72	1.8k

Countries citing papers authored by Naoko Chayahara

Since Specialization

Citations

This map shows the geographic impact of Naoko Chayahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Chayahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Chayahara more than expected).

Fields of papers citing papers by Naoko Chayahara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Chayahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Chayahara. The network helps show where Naoko Chayahara may publish in the future.

Co-authorship network of co-authors of Naoko Chayahara

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Chayahara. A scholar is included among the top collaborators of Naoko Chayahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Chayahara. Naoko Chayahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chayahara, Naoko, et al.. (2023). Drug-Induced Interstitial Lung Disease From PARP Inhibitors (Olaparib and Niraparib) for Ovarian Cancer. SHILAP Revista de lepidopterología. 2(3). 1 indexed citations

Suzuki, Chiaki, Naomi Kiyota, Yoshinori Imamura, et al.. (2021). Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer. Frontiers in Oncology. 11. 638123–638123. 4 indexed citations

Suzuki, Chiaki, Naomi Kiyota, Yoshinori Imamura, et al.. (2018). Exploratory Analysis of Prognostic and Predictive Factors of Lenvatinib for Radioiodine-Refractory Differentiated Thyroid Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1386–1387. 1 indexed citations

Goto, Hideaki, Naomi Kiyota, Naoki Otsuki, et al.. (2018). Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria. Auris Nasus Larynx. 45(6). 1249–1252. 12 indexed citations

Kiyota, Naomi, Naoki Otsuki, Shunsuke Goto, et al.. (2018). Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma. Case Reports in Oncology. 11(3). 735–741. 20 indexed citations

Hayashi, Mitsuhiro, Yoshinori Imamura, Naoko Chayahara, et al.. (2018). Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging. Oncotarget. 9(26). 18540–18547. 11 indexed citations

Takahashi, Shunji, Naomi Kiyota, Tomoko Yamazaki, et al.. (2016). Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.. Journal of Clinical Oncology. 34(15_suppl). 6088–6088. 17 indexed citations

Kataoka, Tomoko, Naomi Kiyota, Yohei Funakoshi, et al.. (2016). Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer. Auris Nasus Larynx. 43(6). 677–684. 27 indexed citations

Toyoda, Masanori, Yoshinori Imamura, Naoko Chayahara, et al.. (2016). The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 77(6). 1165–1170. 15 indexed citations

10.

Funakoshi, Yohei, Yutaka Fujiwara, Naomi Kiyota, et al.. (2016). Validity of new methods to evaluate renal function in cancer patients treated with cisplatin. Cancer Chemotherapy and Pharmacology. 77(2). 281–288. 21 indexed citations

11.

Chayahara, Naoko, Naomi Kiyota, Masanori Toyoda, et al.. (2016). Phase 2 Trial of Bi-weekly Cetuximab for Recurrent or Metastatic Colorectal Cancer (BIC-K Trial). Annals of Oncology. 27. vii77–vii78. 1 indexed citations

12.

Imamura, Yoshinori, Toru Mukohara, Yohei Shimono, et al.. (2015). Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncology Reports. 33(4). 1837–1843. 639 indexed citations breakdown →

13.

Mukohara, Toru, Yohei Funakoshi, Yukiko Nakamura, et al.. (2015). Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study. Case Reports in Oncology. 8(2). 323–331. 1 indexed citations

14.

Fujiwara, Yutaka, Masanori Toyoda, Naoko Chayahara, et al.. (2014). Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide. Clinical Journal of Gastroenterology. 7(3). 255–259. 9 indexed citations

15.

Mukohara, Toru, Yohei Funakoshi, Hideo Tomioka, et al.. (2014). TYRO3 as a potential therapeutic target in breast cancer.. PubMed. 34(7). 3337–45. 28 indexed citations

16.

Fujiwara, Yutaka, Yukio Ando, Toru Mukohara, et al.. (2013). A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(4). 991–998. 5 indexed citations

17.

Funakoshi, Yohei, Yutaka Fujiwara, Naomi Kiyota, et al.. (2013). Prediction of Glomerular Filtration Rate in Cancer Patients by an Equation for Japanese Estimated Glomerular Filtration Rate. Japanese Journal of Clinical Oncology. 43(3). 271–277. 18 indexed citations

18.

Tamura, Takao, Akiko Kuwahara, Kaori Kadoyama, et al.. (2011). Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer. International Journal of Medical Sciences. 8(5). 406–412. 11 indexed citations

19.

Funakoshi, Yohei, Toru Mukohara, Tomoko Kataoka, et al.. (2010). Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma. Rare Tumors. 2(3). 151–153. 11 indexed citations

20.

Sakaeda, Toshiyuki, Motohiro Yamamori, Akiko Kuwahara, et al.. (2008). VEGF G-1154A is Predictive of Severe Acute Toxicities during Chemoradiotherapy for Esophageal Squamous Cell Carcinoma in Japanese Patients. Therapeutic Drug Monitoring. 30(4). 497–503. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact